Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Nirvana Life Sciences Inc NIRVF


Primary Symbol: C.NIRV

Nirvana Life Sciences Inc. is a Canada-based company, which is engaged in the scientific research and development of therapeutic products derived from psychedelics. The Company is also focused on developing methodologies for standardized, quality-controlled extraction and purification of psychoactive compounds. The Company operates in a single reportable segment: research and development of... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >

Current News (CSE:NIRV)

ThreeD Capital Inc. Announces New YouTube Channel

GlobeNewswire March 25, 2024

Nirvana Life Sciences Inc. Announces Receipt of First North American Production of SOSA, a Patented, WHO Approved, Herbal Treatment for Opiate Addiction

Newsfile January 29, 2024

Nirvana Life Sciences Inc. Announces Acquisition of Licensed Distributor of a Patented, WHO Approved, Herbal Treatment for Opiate Addiction

Newsfile August 15, 2023

Nirvana Life Sciences Inc. Announces the Acquisition of Licensed Distributor of a Patented, WHO Approved, Herbal Treatment for Opiate Addiction

Newsfile June 7, 2023

Nirvana Life Sciences Inc. announces agreement to acquire the licensed distributor of a Patented, WHO approved, herbal treatment for opiate addiction

Canada NewsWire November 21, 2022

Nirvana (CSE:NIRV) appoints Sheldon Inwentash to the Board of Directors

Shoran Devi November 9, 2022

Nirvana Life Sciences Inc. Announces the Appointment of Sheldon Inwentash to the Board of Directors

Newsfile November 9, 2022

Nirvana Life Sciences Inc. Deuterates 7-Hydroxymitragynine to Create D7-h, an Analogue that May Improve Research and Formulations using Kratom Derivatives

Canada NewsWire September 22, 2022

Nirvana Life Sciences Inc. Announces a Method for Producing MDMA that Reduces Manufacturing Time by Two Thirds

Canada NewsWire September 7, 2022

Opinion & Analysis (CSE:NIRV)

No current opinion is available.

Bullboard Posts (CSE:NIRV)

Where's the BCSC when you need them? ...

What kind of BS is this!? ... "During the period from incorporation on June 17, 2020 to April 30, 2021, a company controlled by a...
mesa1 - April 3, 2023

RE:NIRV vs MDMA

I'm looking at investing in this sector. Please elaborate. Looking at TRIP, NIRV and ENBI.
ManoloRibera - October 21, 2022

Cleanup on CEO.CA aisle

@bert isn't the only bad actor there. Beware @Acelove with Twitter account caught in P&D of Sensor Technologies SENS
Leerykevin - September 11, 2022

NIRV vs MDMA

Ticker MDMA clearly wins in my opinion...Best Bang for Your Buck....happy to discuss further... doing extensive dd on the sector as a...
Angelized - September 10, 2022

BERT & ERINE

FOLLOW THEM & BUY THEIR SHI T, DUM DUM'S....
crappot - June 22, 2022

Elvira....

LOTS OF DUM DUM'S HERE...
crappot - June 22, 2022